Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortFirst-choice tablet for type 2 diabetes.Sulfonylurea that boosts insulin release.
Body systemDiabetes & WeightDiabetes & Weight
Drug classBiguanidesSulfonylureas
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesType 2 diabetes, Prediabetes (some countries), Gestational diabetes, Polycystic ovary syndrome (off-label)Type 2 diabetes
How it worksMakes your liver release less sugar and helps your body respond to insulin.Tells your pancreas to release more insulin.
Starts workingBlood sugar improves over 1–2 weeks—
Half-lifeAbout 6 hours10–12 hours
Typical adult doseStart 500 mg once or twice a day with meals; increase gradually to 1.5–2 g a day (max 2.55–3 g).40–320 mg a day (split if over 160 mg); modified-release 30–120 mg once a day with breakfast.
FormsTablet, Modified-release tablet, Oral solution, Combination tabletsTablet, Modified-release tablet
Common side effectsDiarrhoea, Nausea, Stomach pain, Metallic taste, Loss of appetiteLow blood sugar, Weight gain, Stomach upset
Serious side effectsLactic acidosis (very rare, mainly with severe kidney failure or acute illness), Vitamin B12 deficiency with long-term useSevere hypoglycaemia, Liver or blood problems (rare)
Don't take ifSevere kidney impairment (eGFR below 30); Acute illness with dehydration, sepsis or shock; Before and after iodinated contrast scans in at-risk patients; Heavy alcohol use or liver diseaseType 1 diabetes or ketoacidosis; Severe kidney or liver impairment; Allergy to sulfonylureas; Taking miconazole
AlcoholBest to limit. Heavy drinking raises the risk of lactic acidosis and low blood sugar.Best to limit. Alcohol raises the risk of severe low blood sugar.
PregnancyGenerally considered safeWidely used for gestational and type 2 diabetes in pregnancy.Usually avoidedUsually switched to insulin or metformin.
BreastfeedingGenerally considered safeConsidered acceptable.Usually avoidedAvoid; insulin preferred.
In use since19571972
Brand namesUnited States: Glucophage, GlumetzaUnited Kingdom: Glucophage, Sukkarto SRIndia: Glycomet, Glyciphage, ObimetUnited Kingdom: Diamicron, ZicronIndia: Glizid, Reclide, DiamicronAustralia: Diamicron MR
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeA10BA02A10BB09

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker